Accrol Group Board now expects year-on-year revenue growth to be c.25% on FY21

Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue converter, has provided a trading update for the current financial year ending 30 April 2022.

In line with the wider market, pressures on the Group’s raw material supply chains have been considerable with further tightening in recent weeks. Pulp and parent reel production costs have been impacted across the world by energy cost increases, input shortages, and general inflationary pressures. Whilst the Group’s supply chain has shown significant resilience and supply shortages have been managed, considerable cost increases had to be absorbed in the short term. In addition, distribution pressures, notably the availability of HGV drivers, which served to increase costs further, have restricted revenue growth in FY22.

These cost increases are successfully being passed on, albeit there will be a time lag in passing on the full impact, resulting in earnings in FY22 being lower than previously expected. Overall, operational efficiencies and integration synergies, together with the successful passing on of cost increases, will enable the Group to deliver FY22 percentage EBITDA1 margins in line with those achieved in FY21.

The market share recovery of the UK discount retail sector within the hygiene category continues to see slow but steady improvement. The Group is maintaining its discipline of targeting only higher value business and avoiding long-term fixed price agreements, especially in this period of volatility. This continues to ensure that revenue growth is of good quality.

As previously indicated, revenues and earnings for FY22 remain weighted to the second half of the financial year. The Board now expects year-on-year revenue growth to be c.25% on FY21 (FY21: £136.6m) and adjusted EBITDA1 in FY22 to improve by c.20% (FY21: £15.6m).

The short-term external challenges facing the business have no effect on the ongoing execution of the Group’s strategy. The business remains in excellent operational shape with scalable foundations for growth and a strong market position across UK retail. Accrol remains well placed to benefit from the ongoing recovery in volumes in the discount sector and a more stable cost environment, as the full effects of the pandemic and broader supply chain and distribution constraints unwind.

Accrol Group continues to operate within its banking covenants and the Group’s liquidity and cash flow position remain robust with adjusted net debt2 expected to remain in line with current market expectations.

A further update will be provided at the Group’s H1 22 results, which will be announced in mid-January 2022.

1  Adjusted EBITDA is defined as profit before finance costs, tax, depreciation, amortisation, separately disclosed items and share based payments

2  Adjusted net debt excludes operating type leases recognised on balance sheet in accordance with IFRS 16

Click to view all articles for the EPIC: ,
Or click to view the full company profile:
Share on facebook
Share on twitter
Share on linkedin
Accrol Group Holdings plc

More articles like this

Accrol Group

Revenues spike for Blackburn toilet paper firm

A toilet paper giant in Blackburn has announced an increased market share among low-cost own-brand products amid the cost of living crisis. Revenues at tissue company Accrol, based on Roman Road, are also booming, according to a trading update released

Accrol Group

Accrol Group launches second ESG report 

Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue converter, has announced that it has today published its latest Environmental, Social and Governance Report, which is available on the Group’s website:   Key report highlights Environmental performance: ·    15%

Accrol Group

Strong performance for toilet roll maker

A toilet paper and tissue maker has reported a rise in revenue with volumes increasing in its latest half-year period. In a trading update ahead of its half-year results for the six months ended 31 October 2022, Accrol

Accrol Group

Accrol Group revenue up 64% to £121.1m

Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue converter, has announced the following trading update ahead of its Half Year Results for the six months ended 31 October 2022, which are scheduled to be released in

Accrol Group

Innovation remains key for UK manufacturing in turbulent times

Innovation is much more than a buzzword. Even in turbulent times, manufacturers cannot afford to rely on the old ways of doing things. That explains why, following years of Brexit-related uncertainty, then the Covid-19 pandemic, and now challenges

Accrol Group

Let UK manufacturers drive the green route to growth

Chris Mould, Audit & Assurance Partner at national audit, tax, advisory and risk firm Crowe in Cheltenham, considers why the government must do more for UK manufacturing.  The UK can carve out a green route to growth if

Accrol Group

Accrol Group: Annual Report & Accounts 2022

Accrol is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towel, facial tissues, and wet wipes. Operational Highlights• Accrol’s market share by volume increased to 19.5% (H1 FY22: 18.9%, FY21 20.0%), compared to flat overall UK

Accrol Group

Tissue manufacturer expands into new base

Tissue maker Accrol has expanded its operational base near Leyland, Lancashire. The manufacturer which produces toilet rolls, kitchen towels, facial tissues and biodegradable wet wipes, is leasing a new logistics building, giving them more space to develop their

Accrol Group

Resilient year at toilet roll maker

A listed business which produces toilet roll, kitchen roll, facial tissue and wet wipe products for most of the UK’s major grocery retailers has reported full-year results covering a resilient performance despite “extremely challenging” macro conditions. Accrol Group

Accrol Group

Tissue maker confident as new financial year begins strongly

Accrol, the AIM-listed Blackburn-based tissue and toilet roll maker, said it is well positioned for the future, after announcing results for the year to April 30, 2022, today. Revenues increased from £136.6m in 2021 to £159.5m this year,

No more posts to show